286 related articles for article (PubMed ID: 29255251)
1. Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance.
le Sage C; Lawo S; Panicker P; Scales TME; Rahman SA; Little AS; McCarthy NJ; Moore JD; Cross BCS
Sci Rep; 2017 Dec; 7(1):17693. PubMed ID: 29255251
[TBL] [Abstract][Full Text] [Related]
2. Advances in therapeutic CRISPR/Cas9 genome editing.
Savić N; Schwank G
Transl Res; 2016 Feb; 168():15-21. PubMed ID: 26470680
[TBL] [Abstract][Full Text] [Related]
3. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Ahmad G; Amiji M
Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
[TBL] [Abstract][Full Text] [Related]
4. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
5. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
[TBL] [Abstract][Full Text] [Related]
6. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
8. In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens.
Chow RD; Wang G; Ye L; Codina A; Kim HR; Shen L; Dong MB; Errami Y; Chen S
Nat Methods; 2019 May; 16(5):405-408. PubMed ID: 30962622
[TBL] [Abstract][Full Text] [Related]
9. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
10. The impact of CRISPR-Cas9 on target identification and validation.
Moore JD
Drug Discov Today; 2015 Apr; 20(4):450-7. PubMed ID: 25572406
[TBL] [Abstract][Full Text] [Related]
11. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
Cho S; Shin J; Cho BK
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
[TBL] [Abstract][Full Text] [Related]
12. Large scale control and programming of gene expression using CRISPR.
Deyell M; Ameta S; Nghe P
Semin Cell Dev Biol; 2019 Dec; 96():124-132. PubMed ID: 31181342
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells.
Daer RM; Cutts JP; Brafman DA; Haynes KA
ACS Synth Biol; 2017 Mar; 6(3):428-438. PubMed ID: 27783893
[TBL] [Abstract][Full Text] [Related]
14. Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.
He Z; Kee K
Methods Mol Biol; 2017; 1498():153-162. PubMed ID: 27709574
[TBL] [Abstract][Full Text] [Related]
15. A Survey of Validation Strategies for CRISPR-Cas9 Editing.
Sentmanat MF; Peters ST; Florian CP; Connelly JP; Pruett-Miller SM
Sci Rep; 2018 Jan; 8(1):888. PubMed ID: 29343825
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
[TBL] [Abstract][Full Text] [Related]
17. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
18. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
19. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
20. RNAi/CRISPR Screens: from a Pool to a Valid Hit.
Schuster A; Erasimus H; Fritah S; Nazarov PV; van Dyck E; Niclou SP; Golebiewska A
Trends Biotechnol; 2019 Jan; 37(1):38-55. PubMed ID: 30177380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
